Judy E. Garber, MD, MPH, Member
BCRF Scientific Advisory Board
Judy Garber is Director of the Cancer Risk and Prevention Program at the Gillette Center for Women's Cancers at Dana-Farber Cancer Institute. She is also an attending physician at Dana-Farber's Breast Evaluation Center, an associate physician at Brigham and Women's Hospital and an associate professor of Medicine at the Harvard Medical School.
Dr. Garber's research is focused on genetic susceptibility to breast, ovarian and other cancers, and the development of novel medical strategies to prevent cancer. She uses the tools of cancer epidemiology and biostatistics, genetics and molecular biology to identify women at high risk for breast cancer.
Dr. Garber is the Leader of the Center for Cancer Genetics and Prevention at the Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard Medical School. She is President of the American Association for Cancer Research, the largest organization of cancer researchers in the world. Dr. Garber is a medical oncologist and clinical cancer geneticist. Her work has focused particularly on the genetics of breast and ovarian cancer, and the management of individuals at increased risk. Her translational research has recently included the evaluation of novel agents targeting DNA repair defects in the treatment and prevention of triple negative or basal-like breast cancer, particularly platinums and PARP inhibitors.
Dr. Garber received her BA from the University of Virginia, and her MD and MPH from Yale University School of Medicine.